Raymond James & Associates’s CAREFUSION CORPORATION CFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-107,858
Closed -$6.4M 2452
2014
Q4
$6.4M Sell
107,858
-121,091
-53% -$6.96M 0.03% 580
2014
Q3
$10.4M Sell
228,949
-7,706
-3% -$347K 0.06% 348
2014
Q2
$10.5M Buy
236,655
+74,079
+46% +$3.07M 0.06% 341
2014
Q1
$6.54M Buy
162,576
+31,936
+24% +$1.29M 0.04% 472
2013
Q4
$5.2M Buy
130,640
+17,579
+16% +$684K 0.04% 519
2013
Q3
$4.17M Buy
113,061
+69,824
+161% +$2.61M 0.04% 545
2013
Q2
$1.59M Buy
+43,237
New +$1.53M 0.02% 928

Other funds holding CFN

Raymond James & Associates's CFN Position: Q1 2015 in Review

Raymond James & Associates sold out of CAREFUSION CORPORATION (CFN) in Q1 2015, closing a stake of 107,858 shares — an estimated $6.4M sold.

Raymond James & Associates first reported a position in CFN in Q2 2013 and held it in 7 quarters. The position peaked at $10.5M in Q2 2014. 3 funds tracked by Wall St. Rank hold CFN as of Q1 2015.

  • Raymond James & Associates reported no remaining CAREFUSION CORPORATION position as of Q1 2015 after selling out during the quarter.
  • Raymond James & Associates sold 107,858 CAREFUSION CORPORATION shares in Q1 2015, an estimated $6.4M.
  • Raymond James & Associates first reported a position in CAREFUSION CORPORATION in Q2 2013 and held it in 7 quarters.
  • Raymond James & Associates's CAREFUSION CORPORATION position peaked at $10.5M in Q2 2014.
  • 3 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q1 2015.

Based on Raymond James & Associates's 13F filing for Q1 2015, filed 28 Apr 2015.